المؤلفون: Zhang J; Department of Endocrinology and., Ma Y; Office of Academic Research, Affiliated Hospital of Hebei University, Baoding, China., Zu Q; Hebei University School of Basic Medical Sciences, Baoding, China., Wang X; Department of Endocrinology and., Zhang Y; Department of Endocrinology and.

المصدر: Medicine [Medicine (Baltimore)] 2024 Sep 27; Vol. 103 (39), pp. e39799.

نوع المنشور: Journal Article; Case Reports

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides*/analogs & derivatives , Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/adverse effects , Diabetic Ketoacidosis*/chemically induced , Diabetic Ketoacidosis*/drug therapy , Glucagon-Like Peptide-1 Receptor*/agonists , Recombinant Fusion Proteins*/adverse effects , Recombinant Fusion Proteins*/therapeutic use , Recombinant Fusion Proteins*/administration & dosage , Hypoglycemic Agents*/adverse effects , Hypoglycemic Agents*/therapeutic use , Immunoglobulin Fc Fragments*/adverse effects , Immunoglobulin Fc Fragments*/therapeutic use , Diabetes Mellitus, Type 2*/drug therapy, Humans ; Female ; Middle Aged ; Latent Autoimmune Diabetes in Adults/drug therapy ; Insulin/adverse effects

المؤلفون: van Boxel EJ; Southampton General Hospital, Southampton, UK elizabeth.vanboxel@uhs.nhs.uk., Rahman S; Queen Alexandra Hospital, Portsmouth, UK., Lai K; Southampton General Hospital, Southampton, UK., Boulos N; Southampton General Hospital, Southampton, UK., Davis N; Southampton General Hospital, Southampton, UK.

المصدر: Archives of disease in childhood [Arch Dis Child] 2024 Sep 25; Vol. 109 (10), pp. 822-825. Date of Electronic Publication: 2024 Sep 25.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: BMJ Pub. Group [etc.] Country of Publication: England NLM ID: 0372434 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2044 (Electronic) Linking ISSN: 00039888 NLM ISO Abbreviation: Arch Dis Child Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/administration & dosage , Weight Loss*/drug effects , Pediatric Obesity*/drug therapy , Pediatric Obesity*/complications , Body Mass Index*, Humans ; Child ; Adolescent ; Male ; Female ; Retrospective Studies ; Treatment Outcome ; Anti-Obesity Agents/therapeutic use ; Anti-Obesity Agents/adverse effects ; Anti-Obesity Agents/administration & dosage

المؤلفون: Lyons D; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland., Louly Nathan A; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland., Pender E; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland., Murray G; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland., Smith C; Charles Institute of Dermatology, University College Dublin, Belfield, Dublin, Ireland.; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland., Kirby B; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.; Charles Institute of Dermatology, University College Dublin, Belfield, Dublin, Ireland., Hughes R; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.; Charles Institute of Dermatology, University College Dublin, Belfield, Dublin, Ireland.

المصدر: The British journal of dermatology [Br J Dermatol] 2024 Sep 18; Vol. 191 (4), pp. 631-633.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Hidradenitis Suppurativa*/drug therapy , Hidradenitis Suppurativa*/complications , Quality of Life* , Weight Loss*/drug effects , Obesity*/drug therapy , Obesity*/complications , Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/administration & dosage, Humans ; Female ; Male ; Adult ; Treatment Outcome ; Middle Aged

المؤلفون: Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Sharma K; Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Borlaug BA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA., Butler J; Baylor Scott and White Research Institute, Dallas, TX, USA.; Department of Medicine, University of Mississippi, Jackson, MS, USA., Davies M; Diabetes Research Centre, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK., Kitzman DW; Department of Internal Medicine, Sections on Cardiovascular Medicine and Geriatrics/Gerontology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Patel S; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA., Chinnakondepalli KM; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA., Einfeldt MN; Novo Nordisk A/S, Søborg, Denmark., Jensen TJ; Novo Nordisk A/S, Søborg, Denmark., Rasmussen S; Novo Nordisk A/S, Søborg, Denmark., Asleh R; Heart Institute, Hadassah University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Ben-Gal T; Heart Failure Unit, Cardiology Department, Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.

المصدر: European heart journal [Eur Heart J] 2024 Sep 14; Vol. 45 (35), pp. 3254-3269.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure*/drug therapy , Heart Failure*/complications , Stroke Volume*/drug effects , Glucagon-Like Peptides*/administration & dosage , Glucagon-Like Peptides*/therapeutic use , Obesity*/complications , Obesity*/drug therapy, Humans ; Female ; Male ; Aged ; Middle Aged ; Sodium Potassium Chloride Symporter Inhibitors/administration & dosage ; Sodium Potassium Chloride Symporter Inhibitors/therapeutic use ; Diuretics/administration & dosage ; Diuretics/therapeutic use ; Treatment Outcome ; Double-Blind Method

المؤلفون: Ostrominski JW; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Chatur S; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA 02115, USA., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.

المصدر: European heart journal [Eur Heart J] 2024 Sep 14; Vol. 45 (35), pp. 3270-3273.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure*/drug therapy , Stroke Volume*/physiology , Stroke Volume*/drug effects , Obesity*/complications , Glucagon-Like Peptides*/administration & dosage , Glucagon-Like Peptides*/therapeutic use, Humans ; Diuretics/therapeutic use ; Diuretics/administration & dosage

المؤلفون: Cortes TM; Division of Endocrinology, Department of Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX, United States.; Sam & Ann Barshop Institute for Longevity & Aging Studies, University of Texas Health Science Center San Antonio, San Antonio, TX, United States.; San Antonio Geriatric Research, Education, and Clinical Center, South Texas Veterans Health Care System, San Antonio, TX, United States., Vasquez L; Texas Diabetes Institute, University Health System, San Antonio, TX, United States., Serra MC; Sam & Ann Barshop Institute for Longevity & Aging Studies, University of Texas Health Science Center San Antonio, San Antonio, TX, United States.; San Antonio Geriatric Research, Education, and Clinical Center, South Texas Veterans Health Care System, San Antonio, TX, United States.; Division of Geriatrics, Gerontology & Palliative Medicine, Department of Medicine, University of Texas Health Science San Antonio, San Antonio, TX, United States., Robbins R; Department of Nutrition and Food Science, Texas Woman's University, Denton, TX, United States., Stepanenko A; Sam & Ann Barshop Institute for Longevity & Aging Studies, University of Texas Health Science Center San Antonio, San Antonio, TX, United States., Brown K; Sam & Ann Barshop Institute for Longevity & Aging Studies, University of Texas Health Science Center San Antonio, San Antonio, TX, United States., Barrus H; Sam & Ann Barshop Institute for Longevity & Aging Studies, University of Texas Health Science Center San Antonio, San Antonio, TX, United States., Campos A; Sam & Ann Barshop Institute for Longevity & Aging Studies, University of Texas Health Science Center San Antonio, San Antonio, TX, United States., Espinoza SE; Division of Geriatrics, Gerontology & Palliative Medicine, Department of Medicine, University of Texas Health Science San Antonio, San Antonio, TX, United States.; Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.; Diabetes and Aging Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States., Musi N; Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.; Diabetes and Aging Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

المصدر: JMIR research protocols [JMIR Res Protoc] 2024 Sep 13; Vol. 13, pp. e62667. Date of Electronic Publication: 2024 Sep 13.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN: 1929-0748 (Electronic) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: MEDLINE

مواضيع طبية MeSH: Body Composition*/drug effects , Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/pharmacology , Biomarkers*/blood , Insulin Resistance* , Overweight*/drug therapy , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood, Humans ; Aged ; Male ; Female ; Aging/drug effects ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/pharmacology ; Prediabetic State/drug therapy ; Prediabetic State/blood ; Physical Functional Performance

المؤلفون: Wang W; Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio., Volkow ND; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Wang Q; Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio., Berger NA; Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio., Davis PB; Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, Ohio., Kaelber DC; Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio., Xu R; Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio.

المصدر: JAMA network open [JAMA Netw Open] 2024 Sep 03; Vol. 7 (9), pp. e2435247. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/adverse effects , Opiate Overdose*/epidemiology , Opioid-Related Disorders*, Humans ; Female ; Male ; Middle Aged ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Adult

المؤلفون: Gasoyan H; Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio.; Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio., Pfoh ER; Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio.; Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio., Schulte R; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Le P; Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio.; Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio., Butsch WS; Department of Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio.; Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio., Rothberg MB; Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio.; Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio.

المصدر: JAMA network open [JAMA Netw Open] 2024 Sep 03; Vol. 7 (9), pp. e2433326. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Liraglutide*/therapeutic use , Weight Loss*/drug effects , Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/analogs & derivatives , Diabetes Mellitus, Type 2*/drug therapy , Obesity*/drug therapy , Hypoglycemic Agents*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Ohio ; Body Mass Index ; Florida

المؤلفون: Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine (M.N.K.)., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, UK (M.C.P.)., Borlaug BA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (B.A.B.).

المصدر: Circulation [Circulation] 2024 Sep 03; Vol. 150 (10), pp. e226-e227. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Letter

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure*/drug therapy , Heart Failure*/physiopathology , Stroke Volume*/drug effects , Quality of Life* , Obesity*/drug therapy , Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/adverse effects, Humans ; Treatment Outcome

المؤلفون: Weir RAP; Cardiology Department, University Hospital Hairmyres, National Health Service Lanarkshire, Scotland, UK.

المصدر: Circulation [Circulation] 2024 Sep 03; Vol. 150 (10), pp. e224-e225. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Letter

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure*/drug therapy , Heart Failure*/physiopathology , Quality of Life* , Obesity*/drug therapy , Stroke Volume*/drug effects , Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/adverse effects, Humans